Sorafenib; BAY 43-9006; Sorafenib Base; Sorafenib Free Base

Size	Availability	Price(USD)	VIP Price (USD)	Quantity
500 mg	In-stock	$126.00	Visible after login	- +
1 g	In-stock	$188.00	Visible after login	- +

Size

Availability

Price(USD)

VIP Price (USD)

Quantity

500 mg

In-stock

$126.00

Visible after login

- +

1 g

In-stock

$188.00

Visible after login

- +

Product Overview

Product Name	Sorafenib; BAY 43-9006; Sorafenib Base; Sorafenib Free Base
CAS	284461-73-0
Formula	C21H16ClF3N4O3
MW	464.82
Appearance	White to off-white powder
Storage condition	Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).

Product details

Sorafenib (BAY549085; BAY-549085; BAY439006; BAY-439006; Nexavar; SFN) an approved anticancer medication, is a potent and orally bioavailable multikinase inhibitor with potential anticancer activity (BAY549085; BAY-549085; BAY439006; BAY-439006; Nexavar; SFN). In enzymatic assays, it inhibits numerous kinases, including Raf-1, B-Raf, and VEGFR-2, with IC50 values of 6 nM, 22 nM, and 90 nM, respectively. The FDA granted sorafenib approval in 2005 to treat advanced renal cancer.

Related literature

Sorry, there is no relevant literature

Sorry, no related items

History